/
/
/

Sai Life Sciences Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
₹554 Cr₹602 Cr₹556 Cr₹537 Cr₹496 Cr₹580 Cr₹440 Cr₹396 Cr₹280 Cr₹439 Cr₹384 Cr
₹4 Cr₹16 Cr₹8 Cr₹15 Cr₹10 Cr₹10 Cr₹9 Cr₹10 Cr₹8 Cr₹3 Cr₹11 Cr
₹558 Cr₹618 Cr₹565 Cr₹553 Cr₹506 Cr₹589 Cr₹449 Cr₹406 Cr₹288 Cr₹443 Cr₹395 Cr
₹452 Cr₹471 Cr₹413 Cr₹431 Cr₹413 Cr₹459 Cr₹354 Cr₹329 Cr₹285 Cr₹346 Cr₹319 Cr
₹152 Cr₹192 Cr₹196 Cr₹161 Cr₹131 Cr₹167 Cr₹129 Cr₹112 Cr₹34 Cr₹128 Cr₹108 Cr
₹8 Cr₹8 Cr₹10 Cr₹9 Cr₹12 Cr₹11 Cr₹23 Cr₹21 Cr₹21 Cr₹21 Cr₹23 Cr
₹98 Cr₹139 Cr₹134 Cr₹112 Cr₹81 Cr₹119 Cr₹72 Cr₹55 Cr-₹18 Cr₹76 Cr₹53 Cr
₹73 Cr₹104 Cr₹100 Cr₹84 Cr₹60 Cr₹88 Cr₹54 Cr₹42 Cr-₹13 Cr₹56 Cr₹40 Cr

Share Price Live Stats

Open (₹)1,590.00
Volume (₹)11.70 L
High (₹)1,616.10
Upper Circuit1,909.30
Low (₹)1,571.40
Lower Circuit1,272.90
Prev Close1,591.10
52W High (₹)1,697.00
Price1,585.00
52W Low (₹)783.85

Share Market Cap & Key Ratios Overview

M.Cap (₹)33822.70 Cr
Div. Yield (%)0.00
PE Ratio93.50
Debt to Equity0.04
Price to Book8.29
Book Value117.07
EPS (TTM)17.03
Face Value1.00
ROE (%)15.16

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
AUROPHARMANSE
DRREDDYNSE
LUPINNSE
MANKINDNSE
SAILIFENSE
LTP
1W Low
1W High
Market cap (₹)
1840-55 (-2.90%)
1834
1907.80
4,47,236Cr
9322+7 (0.08%)
9119.50
9615
2,49,673Cr
4965.5+51.5 (1.05%)
4823
5000
1,87,460Cr
1119.1-37.8 (-3.27%)
1104.60
1167.70
1,11,521Cr
1366-29 (-2.08%)
1347.70
1398.40
1,11,484Cr
1969+92.3 (4.92%)
1832.70
1981.80
1,04,604Cr
1679.8+19.8 (1.19%)
1646
1704
96,031Cr
1165.5+21.3 (1.86%)
1130
1182
95,220Cr
2095-10 (-0.48%)
2058
2135.50
94,883Cr
2280-38 (-1.64%)
2222
2331.60
92,770Cr
1585+5.4 (0.34%)
1567.40
1697
33,823Cr

Key Highlights of Sai Life Sciences Ltd’s P&L

In 2026-03-31, Sai Life Sciences Ltd reported total revenue of ₹2266.89Cr, compared with ₹1731.35Cr in 2025-03-31, reflecting Sai Life Sciences Ltd turnover.

Depreciation was ₹166.85Cr and finance costs were ₹40.88Cr in 2026-03-31

Profit Before Tax (PBT) has been ₹466.19Cr in 2026-03-31 as compared to ₹227.7Cr in 2025-03-31.

Net Profit (PAT) was ₹348.91Cr in 2026-03-31 compared with ₹170.13Cr in 2025-03-31.

Earnings per share (EPS) were ₹16.48 in 2026-03-31, compared with ₹8.16 in 2025-03-31.